Drugdiscovery >> Drugs >> News
12929
Views
title
Bayer’s new hypertension drug to be approved by FDA - drugdiscovery.com


The new drug worked well in clinical trials and is recommended for approval but at lower doses than those proposed by the company.
Read More >>


Tags: Bayer, new drug, hypertension, pulmonary hypertension - August 6, 2013
Related Articles
5748
Views
Bayer's hypertension drug Adempas approved in Canada Bayer's hypertension drug Adempas approved in Canada
The Health Canada has approved the drug Adempas (riociguat) for the treatment of a severe, progressive and life-threatening condition of the heart and lungs, chronic thromboembolic pulmonary hypertens Read More >>

Tags: Adempas, riociguat, Bayer, hypertension drug, thromboembolic, pulmonary hypertension, Canada, approval

6312
Views
Bayer's riociguat approved in two pulmonary hypertension indications Bayer's riociguat approved in two pulmonary hypertension indications
FDA has backed approval of the drug for the treatment of both pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Read More >>

Tags: FDA, approval, Bayer, riociguat, indication, pulmonary arterial hypertension, chronic thromboembolic pulmonary hypertension

5010
Views
Orphan drug designation for Bayer’s hypertension drug riociguat Orphan drug designation for Bayer’s hypertension drug riociguat
The FDA has granted two separate orphan drug designations for riociguat, Bayer’s investigational hypertension drug, for the treatment of pulmonary arterial hypertension and chronic thromboembolic pu Read More >>

Tags: riociguat, hypertension, drug, orphan drug designation, orphan, Bayer, pulmonary arterial hypertension, chronic thromboembolic pulmonary hypertension

4426
Views
FDA approves Adempas for the treatment of two forms of pulmonary hypertension FDA approves Adempas for the treatment of two forms of pulmonary hypertension
Bayer HealthCare’s drug Adempas (riociguat) is approved by the FDA for the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) after surgical treatmen Read More >>

Tags: Adempas, riociguat, treatment, drug, pulmonary hypertension, pulmonary arterial hypertension, chronic thromboembolic pulmonary hypertension

5611
Views
A  high blood pressure drug approved for kids too A high blood pressure drug approved for kids too
FDA has approved Silvergate Pharmaceuticals’ drug Epaned (enalapril maleate powder for oral solution) for the treatment of hypertension in patients aged one month and older. Read More >>

Tags: Epaned, hypertension, high blood pressure, children, pediatric patients

10070
Views
Another Sanofi MS drug approved in EU Another Sanofi MS drug approved in EU
After Aubagio, Lemtrada - another Sanofi’s drug for treatment of multiple sclerosis has been approved by the European Commission. Read More >>

Tags: multiple sclerosis, Europe, new drug, Aubagio, Lemtrada

14323
Views
How Drugs are Developed and Approved How Drugs are Developed and Approved
In the United States, all medications except natural remedies and supplements, must go through an approval process before they can be made available to people. The Food and Drug Administration (FDA) i Read More >>

Tags: FDA, CDER, drug safety

7949
Views
Takeda's schizophrenia drug lurasidone approved in Swiss Takeda's schizophrenia drug lurasidone approved in Swiss
This is the first approval in Europe for lurasidone, which is already marketed as Latuda for schizophrenia and bipolar depression in the US and Canada. Read More >>

Tags: lurasidone, latuda, drug, schizophrenia, bipoloar disorder, Swiss, approval, Europe

11690
Views
New drug for treating myeloma approved in Europe New drug for treating myeloma approved in Europe
The European Commission has granted approval for Celgene’s drug pomalidomide for the treatment of relapsed and refractory multiple myeloma, in combination with dexamethasone. The marketing name of Read More >>

Tags: Celgene, pomalidomide, multiple myeloma,Imnovid,the European Commission approval

7163
Views
Astellas’ diarrhea drug - Irribow approved in Japan Astellas’ diarrhea drug - Irribow approved in Japan
Astellas Pharma announced the approval of the additional formulation of Irribow OD Tablets for treatment of diarrhea-predominant irritable bowel syndrome in Japan. Read More >>

Tags: Irribow, Astellas, diarrhea, irritable bowel syndrome, approval

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013